Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure

Detalhes bibliográficos
Autor(a) principal: Alexandre, Cristianne Silva
Data de Publicação: 2009
Outros Autores: Volpini, Rildo Aparecido, Shimizu, Maria Heloisa, Sanches, Talita Rojas, Semedo, Patricia [UNIFESP], Di Jura, Vera Lucia, Camara, Niels Olsen [UNIFESP], Seguro, Antonio Carlos, Andrade, Lucia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1634/stemcells.2008-0496
http://repositorio.unifesp.br/handle/11600/31128
Resumo: Progressive renal failure continues to be a challenge. the use of bone marrow cells represents a means of meeting that challenge. We used lineage-negative (Lin(-)) cells to test the hypothesis that Lin(-) cell treatment decreases renal injury. Syngeneic Fischer 344 rats were divided into four groups: sham ( laparotomy only, untreated); Nx (five-sixth nephrectomy and untreated); NxLC1 (five-sixth nephrectomy and receiving 2 x 10(6) Lin(-) cells on postnephrectomy day 15); and NxLC3 (five-sixth nephrectomy and receiving 2 x 10(6) Lin(-) cells on postnephrectomy days 15, 30, and 45). On postoperative day 16, renal mRNA expression of interleukin (IL)-1 beta, tumor necrosis factor-alpha, and IL-6 was lower in NxLC rats than in Nx rats. On postnephrectomy day 60, NxLC rats presented less proteinuria, glomerulosclerosis, anemia, renal infiltration of immune cells, and protein expression of monocyte chemoattractant protein-1, as well as decreased interstitial area. Immunostaining for proliferating cell nuclear antigen showed that, in comparison with sham rats, Nx rats presented greater cell proliferation, whereas NxLC1 rats and NxLC3 rats presented less cell proliferation than did Nx rats. Protein expression of the cyclin-dependent kinase inhibitor p21 and of vascular endothelial growth factor increased after nephrectomy and decreased after Lin(-) cell treatment. On postnephrectomy day 120, renal function (inulin clearance) was significantly better in Lin(-) cell-treated rats than in untreated rats. Lin(-) cell treatment significantly improved survival. These data suggest that Lin(-) cell treatment protects against chronic renal failure. STEM CELLS 2009; 27: 682-692
id UFSP_79d6f79d39f10ca908da4f9812c0929f
oai_identifier_str oai:repositorio.unifesp.br/:11600/31128
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal FailureHematopoietic stem cellsNephrectomyKidney failureChronic proteinuriaFibrosis/pathologyProliferating cell nuclear antigenProgressive renal failure continues to be a challenge. the use of bone marrow cells represents a means of meeting that challenge. We used lineage-negative (Lin(-)) cells to test the hypothesis that Lin(-) cell treatment decreases renal injury. Syngeneic Fischer 344 rats were divided into four groups: sham ( laparotomy only, untreated); Nx (five-sixth nephrectomy and untreated); NxLC1 (five-sixth nephrectomy and receiving 2 x 10(6) Lin(-) cells on postnephrectomy day 15); and NxLC3 (five-sixth nephrectomy and receiving 2 x 10(6) Lin(-) cells on postnephrectomy days 15, 30, and 45). On postoperative day 16, renal mRNA expression of interleukin (IL)-1 beta, tumor necrosis factor-alpha, and IL-6 was lower in NxLC rats than in Nx rats. On postnephrectomy day 60, NxLC rats presented less proteinuria, glomerulosclerosis, anemia, renal infiltration of immune cells, and protein expression of monocyte chemoattractant protein-1, as well as decreased interstitial area. Immunostaining for proliferating cell nuclear antigen showed that, in comparison with sham rats, Nx rats presented greater cell proliferation, whereas NxLC1 rats and NxLC3 rats presented less cell proliferation than did Nx rats. Protein expression of the cyclin-dependent kinase inhibitor p21 and of vascular endothelial growth factor increased after nephrectomy and decreased after Lin(-) cell treatment. On postnephrectomy day 120, renal function (inulin clearance) was significantly better in Lin(-) cell-treated rats than in untreated rats. Lin(-) cell treatment significantly improved survival. These data suggest that Lin(-) cell treatment protects against chronic renal failure. STEM CELLS 2009; 27: 682-692Univ São Paulo, Sch Med, Fac Med,Lab Pesquisa Basica LIM 12, Dept Nephrol, BR-01246903 São Paulo, BrazilUniversidade Federal de São Paulo, Dept Nephrol, São Paulo, BrazilUniv São Paulo, Dept Immunol, BR-01246903 São Paulo, BrazilUniversidade Federal de São Paulo, Dept Nephrol, São Paulo, BrazilWeb of ScienceAlphamed PressUniversidade de São Paulo (USP)Universidade Federal de São Paulo (UNIFESP)Alexandre, Cristianne SilvaVolpini, Rildo AparecidoShimizu, Maria HeloisaSanches, Talita RojasSemedo, Patricia [UNIFESP]Di Jura, Vera LuciaCamara, Niels Olsen [UNIFESP]Seguro, Antonio CarlosAndrade, Lucia2016-01-24T13:52:01Z2016-01-24T13:52:01Z2009-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion682-692http://dx.doi.org/10.1634/stemcells.2008-0496Stem Cells. Durham: Alphamed Press, v. 27, n. 3, p. 682-692, 2009.10.1634/stemcells.2008-04961066-5099http://repositorio.unifesp.br/handle/11600/31128WOS:000264706900019engStem Cellsinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2016-01-24T11:52:01Zoai:repositorio.unifesp.br/:11600/31128Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652016-01-24T11:52:01Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure
title Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure
spellingShingle Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure
Alexandre, Cristianne Silva
Hematopoietic stem cells
Nephrectomy
Kidney failure
Chronic proteinuria
Fibrosis/pathology
Proliferating cell nuclear antigen
title_short Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure
title_full Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure
title_fullStr Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure
title_full_unstemmed Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure
title_sort Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure
author Alexandre, Cristianne Silva
author_facet Alexandre, Cristianne Silva
Volpini, Rildo Aparecido
Shimizu, Maria Heloisa
Sanches, Talita Rojas
Semedo, Patricia [UNIFESP]
Di Jura, Vera Lucia
Camara, Niels Olsen [UNIFESP]
Seguro, Antonio Carlos
Andrade, Lucia
author_role author
author2 Volpini, Rildo Aparecido
Shimizu, Maria Heloisa
Sanches, Talita Rojas
Semedo, Patricia [UNIFESP]
Di Jura, Vera Lucia
Camara, Niels Olsen [UNIFESP]
Seguro, Antonio Carlos
Andrade, Lucia
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Alexandre, Cristianne Silva
Volpini, Rildo Aparecido
Shimizu, Maria Heloisa
Sanches, Talita Rojas
Semedo, Patricia [UNIFESP]
Di Jura, Vera Lucia
Camara, Niels Olsen [UNIFESP]
Seguro, Antonio Carlos
Andrade, Lucia
dc.subject.por.fl_str_mv Hematopoietic stem cells
Nephrectomy
Kidney failure
Chronic proteinuria
Fibrosis/pathology
Proliferating cell nuclear antigen
topic Hematopoietic stem cells
Nephrectomy
Kidney failure
Chronic proteinuria
Fibrosis/pathology
Proliferating cell nuclear antigen
description Progressive renal failure continues to be a challenge. the use of bone marrow cells represents a means of meeting that challenge. We used lineage-negative (Lin(-)) cells to test the hypothesis that Lin(-) cell treatment decreases renal injury. Syngeneic Fischer 344 rats were divided into four groups: sham ( laparotomy only, untreated); Nx (five-sixth nephrectomy and untreated); NxLC1 (five-sixth nephrectomy and receiving 2 x 10(6) Lin(-) cells on postnephrectomy day 15); and NxLC3 (five-sixth nephrectomy and receiving 2 x 10(6) Lin(-) cells on postnephrectomy days 15, 30, and 45). On postoperative day 16, renal mRNA expression of interleukin (IL)-1 beta, tumor necrosis factor-alpha, and IL-6 was lower in NxLC rats than in Nx rats. On postnephrectomy day 60, NxLC rats presented less proteinuria, glomerulosclerosis, anemia, renal infiltration of immune cells, and protein expression of monocyte chemoattractant protein-1, as well as decreased interstitial area. Immunostaining for proliferating cell nuclear antigen showed that, in comparison with sham rats, Nx rats presented greater cell proliferation, whereas NxLC1 rats and NxLC3 rats presented less cell proliferation than did Nx rats. Protein expression of the cyclin-dependent kinase inhibitor p21 and of vascular endothelial growth factor increased after nephrectomy and decreased after Lin(-) cell treatment. On postnephrectomy day 120, renal function (inulin clearance) was significantly better in Lin(-) cell-treated rats than in untreated rats. Lin(-) cell treatment significantly improved survival. These data suggest that Lin(-) cell treatment protects against chronic renal failure. STEM CELLS 2009; 27: 682-692
publishDate 2009
dc.date.none.fl_str_mv 2009-01-01
2016-01-24T13:52:01Z
2016-01-24T13:52:01Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1634/stemcells.2008-0496
Stem Cells. Durham: Alphamed Press, v. 27, n. 3, p. 682-692, 2009.
10.1634/stemcells.2008-0496
1066-5099
http://repositorio.unifesp.br/handle/11600/31128
WOS:000264706900019
url http://dx.doi.org/10.1634/stemcells.2008-0496
http://repositorio.unifesp.br/handle/11600/31128
identifier_str_mv Stem Cells. Durham: Alphamed Press, v. 27, n. 3, p. 682-692, 2009.
10.1634/stemcells.2008-0496
1066-5099
WOS:000264706900019
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Stem Cells
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 682-692
dc.publisher.none.fl_str_mv Alphamed Press
publisher.none.fl_str_mv Alphamed Press
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268404079525888